Company Overview
Snapshot
Founded in December 2022 by Ofer Barshem, Cell-Lipo operates with 1–10 employees. The company has raised $977,769 across two funding rounds from one investor.
Business overview
Cell-Lipo develops accessible, science-based regenerative stem cell solutions aimed at improving aesthetic treatments and providing relief for chronic disorders. The company's core technology integrates advanced laser-assisted liposuction with a proprietary mechanical stem cell separation method, enabling rapid, sterile, and cost-effective isolation of stem cells from fat tissue. This closed medical system, protected by a patent, offers a sustainable alternative to enzymatic isolation methods. Cell-Lipo serves the health tech and life sciences sectors, with applications in orthopedics for conditions like osteoarthritis and sport injuries, alongside aesthetic applications.
Log in to access full profile ›Company Intelligence Q&A
- What is Cell-Lipo's primary focus?
- Cell-Lipo focuses on personalized cell therapy, utilizing regenerative stem cell solutions to enhance aesthetic treatments and address chronic disorders.
- When was Cell-Lipo founded?
- Cell-Lipo was founded in December 2022.
- Who is the CEO of Cell-Lipo?
- Ofer Barshem is the Co-founder & CEO of Cell-Lipo.
- What is Cell-Lipo's core technology?
- Cell-Lipo's core technology involves a patent-protected, closed medical system that combines advanced laser-assisted liposuction with a proprietary mechanical stem cell separation method for isolating stem cells from fat tissue.